Shafiq Mohammed Choudhary
Chief Operating Officer at Peckforton Pharmaceuticals Ltd.
Net worth: - $ as of 2024-05-30
Shafiq Mohammed Choudhary active positions
Companies | Position | Start | End |
---|---|---|---|
Esteve Pharmaceuticals Ltd.
Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Director/Board Member | - | - |
Peckforton Pharmaceuticals Ltd.
Peckforton Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Peckforton Pharmaceuticals Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. It is focused into two divisions, Branded and Hospital. Each division has distinct and separate requirements to support both the patient and the healthcare professional. The company was founded on April 11, 1995 and is headquartered in Crewe, the United Kingdom. | Director/Board Member | 2014-08-06 | - |
Chief Operating Officer | 2014-08-06 | - |
Career history of Shafiq Mohammed Choudhary
Former positions of Shafiq Mohammed Choudhary
Companies | Position | Start | End |
---|---|---|---|
Tetris Pharma Ltd.
Tetris Pharma Ltd. Medical DistributorsDistribution Services Part of Arecor Therapeutics Plc, Tetris Pharma Ltd. is a British company that sells and distributes pharmaceutical products. The company is based in Marlow, UK. The CEO of the company is Shafiq Choudhary. Tetris Pharma was acquired by Arecor Therapeutics Plc on August 04, 2022 for $7.33 million. | Chief Executive Officer | - | 2023-09-21 |
Abbey Pharma Ltd.
Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Director/Board Member | - | 2020-09-29 |
Statistics
International
United Kingdom | 5 |
Operational
Director/Board Member | 3 |
Chief Operating Officer | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 4 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Abbey Pharma Ltd.
Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Esteve Pharmaceuticals Ltd.
Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Peckforton Pharmaceuticals Ltd.
Peckforton Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Peckforton Pharmaceuticals Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. It is focused into two divisions, Branded and Hospital. Each division has distinct and separate requirements to support both the patient and the healthcare professional. The company was founded on April 11, 1995 and is headquartered in Crewe, the United Kingdom. | Health Technology |
Tetris Pharma Ltd.
Tetris Pharma Ltd. Medical DistributorsDistribution Services Part of Arecor Therapeutics Plc, Tetris Pharma Ltd. is a British company that sells and distributes pharmaceutical products. The company is based in Marlow, UK. The CEO of the company is Shafiq Choudhary. Tetris Pharma was acquired by Arecor Therapeutics Plc on August 04, 2022 for $7.33 million. | Distribution Services |